D2 receptor | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,240 results for “D2 receptor”

Trials

View all 5917 →

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

11 participants · First posted Aug 29, 2013

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

8 participants · First posted Feb 28, 2008

A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone

28 participants · First posted Nov 8, 2013

Drugs

View all 1339 →

Prostaglandin D2 receptor antagonist (Actelion)

D2 receptor agonists (University of Toronto)

dopamine D2 receptor positive allosteric modulators (UCB Pharma)

Organizations

View all 30 →

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

News

View all 4954 →

IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression

TAK-906: Peripheral D2/D3 Antagonist Under Development for Gastroparesis

Bristol Myers Squibb Soars as AbbVie's Schizophrenia Drug Fails Trial

Page 1 of 1224